Do you want to learn how far along they are in developing
drugs for certain
diseases and what their plans are?
That kind of information was always hard to find and expensive.
Until
...a monthly, from CTB International Publishing,
Inc., publisher of
BIOTECHNOLOGY NEWS, EMERGING PHARMACEUTICALS, CLINICAL
TRIALS MONITOR, CLINICAL INVESTIGATOR NEWS, DIAGNOSTICS INTELLIGENCE and
PHARMACEUTICAL NEWS DAILY.
Now you can receive a four-page table that summarizes
the changes in the drug development plans of companies in the U.S. and
Canada.
Every month the four pages of DRUG DEVELOPMENT PIPELINE
will alert you to 120+entries on products moving through companies pipelines.
You can subscribe to the Drug Development Pipeline
at the unbelievably low cost of $175/year. This is the most cost-effective,
lowest priced source of up-to-date, commercial drug development information
available anywhere.
Look over the sample page , and
you'll see that this is a valuable tool you can't afford to be without.
1
